More Galleries
5 startups that are reimagining the world Bricks that grow from microorganisms, household garbage turned into art, three-wheeled bike-cars -- these startups are redefining urban living. More
Blue collar entrepreneurs These five entrepreneurs took their blue collar experience and used it to launch innovative businesses. More
7 lifehacks to eliminate your holiday hassle Whether curating the perfect gift or finding a pet-sitter, these startups offer time-saving services that might just seem like holiday magic. More

Special Offer
13 of 36
Outsourced drug research
Outsourced drug research
Amin Zargar, Varnika Roy, Dean Larios Berlin
Team name: Callinix

School: University of Maryland College Park, Clark School of Engineering

Team members: Amin Zargar, Varnika Roy, Dean Larios Berlin

Concept: Callinix aims to help large pharmaceutical firms conduct drug screening and delivery research. Every year, Big Pharma develops thousands of drugs that either remain in pre-clinical stages or are denied FDA approval. These underdeveloped compounds often get sidelined because they are deemed unstable or have side effects.

Callinix positions itself as an outsourced testing partner that will screen the drugs and find more effective ways to deliver them to their targeted tissue. Initially the company plans to target cancer-fighting compounds. It also plans to sell improved drug packaging that it claims will extend the commercial life of existing drugs.

Timeline: Callinix projects that the company will start generating revenue in year three ($325,000) and will more than double sales in each of the following four years. The company expects to become profitable by year four. - Brandi Stewart

NEXT: A new way to halt seizures

Last updated May 02 2008: 11:51 AM ET